Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 815

1.

Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial.

Inagaki N, Yang W, Watada H, Ji L, Schnaidt S, Pfarr E, Okamura T, Johansen OE, George JT, von Eynatten M, Rosenstock J, Perkovic V, Wanner C, Cooper ME, Alexander JH, Komuro I, Nangaku M.

Diabetol Int. 2019 Oct 22;11(2):129-141. doi: 10.1007/s13340-019-00412-x. eCollection 2020 Apr.

PMID:
32206483
2.

Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.

Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M.

J Endocr Soc. 2020 Feb 13;4(4):bvaa011. doi: 10.1210/jendso/bvaa011. eCollection 2020 Apr 1.

3.

Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease.

Yamamoto Y, Kojima K, Taura D, Sone M, Washida K, Egawa N, Kondo T, Minakawa EN, Tsukita K, Enami T, Tomimoto H, Mizuno T, Kalaria RN, Inagaki N, Takahashi R, Harada-Shiba M, Ihara M, Inoue H.

Mol Brain. 2020 Mar 19;13(1):38. doi: 10.1186/s13041-020-00573-w.

4.

Enteroendocrine K Cells Exert Complementary Effects to Control Bone Quality and Mass in Mice.

Gobron B, Bouvard B, Vyavahare S, Blom LV, Pedersen KK, Windeløv JA, Boer GA, Harada N, Zhang S, Shimazu-Kuwahara S, Wice B, Inagaki N, Legrand E, Flatt PR, Chappard D, Hartmann B, Holst JJ, Rosenkilde MM, Irwin N, Mabilleau G.

J Bone Miner Res. 2020 Mar 10. doi: 10.1002/jbmr.4004. [Epub ahead of print]

PMID:
32155286
5.

Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database.

Minamino H, Katsushima M, Yoshida T, Hashimoto M, Fujita Y, Shirakashi M, Yamamoto W, Murakami K, Murata K, Nishitani K, Tanaka M, Ito H, Inagaki N, Matsuda S.

PLoS One. 2020 Mar 3;15(3):e0229998. doi: 10.1371/journal.pone.0229998. eCollection 2020.

6.

Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome.

Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo T, Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group.

Eur J Endocrinol. 2020 Mar;182(3):265-273. doi: 10.1530/EJE-19-0860.

PMID:
32038030
7.

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Classes of Glucose-Lowering Medications on Renal Outcome in Type 2 Diabetes.

Takeuchi M, Ogura M, Minoura T, Inagaki N, Kawakami K.

Mayo Clin Proc. 2020 Feb;95(2):265-273. doi: 10.1016/j.mayocp.2019.12.004.

8.

Absence of GIP secretion alleviates age-related obesity and insulin resistance.

Kanemaru Y, Harada N, Shimazu-Kuwahara S, Yamane S, Ikeguchi E, Murata Y, Kiyobayashi S, Hatoko T, Inagaki N.

J Endocrinol. 2020 Jan 1. pii: JOE-19-0477.R1. doi: 10.1530/JOE-19-0477. [Epub ahead of print]

9.

C-Type Natriuretic Peptide Restores Growth Impairment Under Enzyme Replacement in Mice With Mucopolysaccharidosis VII.

Yamashita T, Fujii T, Yamauchi I, Ueda Y, Hirota K, Kanai Y, Yasoda A, Inagaki N.

Endocrinology. 2020 Feb 1;161(2). pii: bqaa008. doi: 10.1210/endocr/bqaa008.

PMID:
31974587
10.

The rhizobial autotransporter determines the symbiotic nitrogen fixation activity of Lotus japonicus in a host-specific manner.

Shimoda Y, Nishigaya Y, Yamaya-Ito H, Inagaki N, Umehara Y, Hirakawa H, Sato S, Yamazaki T, Hayashi M.

Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1806-1815. doi: 10.1073/pnas.1913349117. Epub 2020 Jan 3.

PMID:
31900357
11.

Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with 111In-labeled exendin-4.

Hamamatsu K, Fujimoto H, Fujita N, Murakami T, Shiotani M, Toyoda K, Inagaki N.

Sci Rep. 2019 Dec 4;9(1):18338. doi: 10.1038/s41598-019-54722-w.

12.

Factory-calibrated continuous glucose monitoring and capillary blood glucose monitoring in a case with insulinoma: usefulness and possible pitfall under chronic hyperinsulinemic hypoglycemia.

Suminaga K, Murakami T, Yabe D, Sone M, Sugawa T, Masui T, Uza N, Yoshizawa A, Ogura M, Yasoda A, Inagaki N.

Endocr J. 2019 Nov 23. doi: 10.1507/endocrj.EJ19-0339. [Epub ahead of print]

13.

Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2.

Kitasato S, Tanaka T, Chazono M, Komaki H, Kakuta A, Inagaki N, Akiyama S, Marumo K.

J Biomed Mater Res A. 2020 Mar;108(3):528-536. doi: 10.1002/jbm.a.36833. Epub 2019 Nov 23.

PMID:
31702866
14.

GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells.

Usui R, Yabe D, Fauzi M, Goto H, Botagarova A, Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera PL, Ogura M, Nagashima K, Inagaki N.

Sci Rep. 2019 Oct 29;9(1):15562. doi: 10.1038/s41598-019-52048-1.

15.

Ceritinib-associated hyperglycemia in the Japanese Adverse Drug Event Report Database.

Fujita H, Murakami T, Tomoike F, Yabe D, Inagaki N.

J Diabetes Investig. 2019 Oct 29. doi: 10.1111/jdi.13168. [Epub ahead of print]

16.

A combination of dietary fat intake and nicotine exposure enhances CB1 endocannabinoid receptor expression in hypothalamic nuclei in male mice.

Guo T, Tanaka T, Matsumoto M, Kaneko K, Unzai T, Ogino Y, Aotani D, Kusakabe T, Iwakura H, Miyazawa T, Sawamoto K, Minokoshi Y, Masuzaki H, Inagaki N, Nakao K.

Neurosci Lett. 2020 Jan 1;714:134550. doi: 10.1016/j.neulet.2019.134550. Epub 2019 Oct 18.

PMID:
31634502
17.

Evaluation of image quality of pituitary dynamic contrast-enhanced MRI using time-resolved angiography with interleaved stochastic trajectories (TWIST) and iterative reconstruction TWIST (IT-TWIST).

Yokota Y, Fushimi Y, Okada T, Fujimoto K, Oshima S, Nakajima S, Fujii T, Tanji M, Inagaki N, Miyamoto S, Togashi K.

J Magn Reson Imaging. 2019 Oct 18. doi: 10.1002/jmri.26962. [Epub ahead of print]

PMID:
31625655
18.

Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.

Murakami T, Fujimoto H, Fujita N, Hamamatsu K, Matsumoto K, Inagaki N.

Endocrinology. 2019 Dec 1;160(12):2959-2968. doi: 10.1210/en.2019-00556.

PMID:
31613319
19.

Pyroglutamyl leucine, a peptide in fermented foods, attenuates dysbiosis by increasing host antimicrobial peptide.

Shirako S, Kojima Y, Tomari N, Nakamura Y, Matsumura Y, Ikeda K, Inagaki N, Sato K.

NPJ Sci Food. 2019 Oct 7;3:18. doi: 10.1038/s41538-019-0050-z. eCollection 2019.

20.

Update on the efficacy and safety of sodium-glucose cotransporter 2 inhibitors in Asians and non-Asians.

Fujita Y, Inagaki N.

J Diabetes Investig. 2019 Nov;10(6):1408-1410. doi: 10.1111/jdi.13150. Epub 2019 Oct 14. No abstract available.

21.

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M; JPAS Study Group.

J Hum Hypertens. 2020 Jan;34(1):34-42. doi: 10.1038/s41371-019-0229-4. Epub 2019 Aug 28.

PMID:
31462725
22.

Shootins mediate collective cell migration and organogenesis of the zebrafish posterior lateral line system.

Urasaki A, Morishita S, Naka K, Uozumi M, Abe K, Huang L, Watase E, Nakagawa O, Kawakami K, Matsui T, Bessho Y, Inagaki N.

Sci Rep. 2019 Aug 21;9(1):12156. doi: 10.1038/s41598-019-48585-4.

23.

Retrieval strategy for ruptured balloon with circumferential tear during angioplasty for arteriovenous fistula in hemodialysis patients.

Murata R, Kamiizumi Y, Haneda T, Ishizuka C, Kashiwakura S, Tsuji T, Kasai H, Tani Y, Inagaki N, Chiba S, Ito K.

J Vasc Access. 2020 Mar;21(2):246-250. doi: 10.1177/1129729819870634. Epub 2019 Aug 22.

PMID:
31434523
24.
25.

Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study.

Nakamura T, Fujikura J, Anazawa T, Ito R, Ogura M, Okajima H, Uemoto S, Inagaki N.

J Diabetes Investig. 2020 Mar;11(2):363-372. doi: 10.1111/jdi.13128. Epub 2019 Sep 17.

26.

Effects of micro-porosity and local BMP-2 administration on bioresorption of β-TCP and new bone formation.

Kakuta A, Tanaka T, Chazono M, Komaki H, Kitasato S, Inagaki N, Akiyama S, Marumo K.

Biomater Res. 2019 Jul 26;23:12. doi: 10.1186/s40824-019-0161-2. eCollection 2019.

27.

Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4.

Fujita N, Fujimoto H, Hamamatsu K, Murakami T, Kimura H, Toyoda K, Saji H, Inagaki N.

FASEB J. 2019 Nov;33(11):11836-11844. doi: 10.1096/fj.201900555RR. Epub 2019 Aug 1.

PMID:
31370679
28.

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M; JPAS/JRAS Study Group.

Hypertension. 2019 Sep;74(3):630-638. doi: 10.1161/HYPERTENSIONAHA.119.13131. Epub 2019 Jul 22.

PMID:
31327258
29.

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M.

Eur J Endocrinol. 2019 Sep;181(3):339-350. doi: 10.1530/EJE-19-0047.

PMID:
31319380
30.

An influenza-derived membrane tension-modulating peptide regulates cell movement and morphology via actin remodeling.

Masuda T, Baba K, Nomura T, Tsujita K, Murayama T, Itoh T, Takatani-Nakase T, Sokabe M, Inagaki N, Futaki S.

Commun Biol. 2019 Jun 26;2:243. doi: 10.1038/s42003-019-0486-3. eCollection 2019.

31.

Exogenous C-type natriuretic peptide therapy for impaired skeletal growth in a murine model of glucocorticoid treatment.

Ueda Y, Yasoda A, Hirota K, Yamauchi I, Yamashita T, Kanai Y, Sakane Y, Fujii T, Inagaki N.

Sci Rep. 2019 Jun 12;9(1):8547. doi: 10.1038/s41598-019-44975-w.

32.

Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.

Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS/JRAS Study Group.

J Hypertens. 2019 Jul;37(7):1513-1520. doi: 10.1097/HJH.0000000000002070.

PMID:
31145370
33.

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.

Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim YH, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N.

PLoS One. 2019 May 14;14(5):e0216954. doi: 10.1371/journal.pone.0216954. eCollection 2019.

34.

Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.

Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M; JPAS/JRAS Study Group.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4382-4389. doi: 10.1210/jc.2018-02790.

PMID:
31058960
35.

Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.

Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, Naruse M; JPAS Study Group.

J Hypertens. 2019 Jul;37(7):1493-1499. doi: 10.1097/HJH.0000000000002047.

PMID:
31033727
36.

High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan.

Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M; Japan Primary Aldosteronism Study Group.

Diabetes Care. 2019 May;42(5):938-945. doi: 10.2337/dc18-1293.

PMID:
31010944
37.

Free fatty acid receptors, G protein-coupled receptor 120 and G protein-coupled receptor 40, are essential for oil-induced gastric inhibitory polypeptide secretion.

Sankoda A, Harada N, Kato T, Ikeguchi E, Iwasaki K, Yamane S, Murata Y, Hirasawa A, Inagaki N.

J Diabetes Investig. 2019 Nov;10(6):1430-1437. doi: 10.1111/jdi.13059. Epub 2019 May 7.

38.

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: A retrospective cohort study.

Oshima A, Nishimura A, Chen-Yoshikawa TF, Harashima SI, Komatsu T, Handa T, Aoyama A, Takahashi K, Ikeda M, Oshima Y, Ikezoe K, Sato S, Isomi M, Shide K, Date H, Inagaki N.

Clin Transplant. 2019 Jun;33(6):e13566. doi: 10.1111/ctr.13566. Epub 2019 May 12.

PMID:
31002178
39.

Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.

Murata Y, Harada N, Yamane S, Iwasaki K, Ikeguchi E, Kanemaru Y, Harada T, Sankoda A, Shimazu-Kuwahara S, Joo E, Poudyal H, Inagaki N.

Am J Physiol Endocrinol Metab. 2019 Jul 1;317(1):E53-E64. doi: 10.1152/ajpendo.00200.2018. Epub 2019 Apr 16. Erratum in: Am J Physiol Endocrinol Metab. 2020 Mar 1;318(3):E440.

PMID:
30990747
40.

Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology.

Murakami T, Yabe D, Inagaki N.

J Diabetes Investig. 2019 Sep;10(5):1168-1170. doi: 10.1111/jdi.13060. Epub 2019 May 14.

41.

Reversal of Cushing Pigmentation by Sunitinib.

Iwasaki Y, Sone M, Inagaki N.

J Endocr Soc. 2019 Feb 13;3(4):714-715. doi: 10.1210/js.2018-00415. eCollection 2019 Apr 1. No abstract available.

42.

Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study.

Nishimura A, Harashima SI, Hosoda K, Arai H, Inagaki N.

Ther Adv Endocrinol Metab. 2019 Mar 5;10:2042018819833304. doi: 10.1177/2042018819833304. eCollection 2019.

43.

IFN-γ Reduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model.

Kanoh H, Ishitsuka A, Fujine E, Matsuhaba S, Nakamura M, Ito H, Inagaki N, Banno Y, Seishima M.

J Immunol Res. 2019 Jan 29;2019:3030268. doi: 10.1155/2019/3030268. eCollection 2019.

44.

Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.

Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N.

FASEB J. 2019 May;33(5):6239-6253. doi: 10.1096/fj.201801783RR. Epub 2019 Feb 21.

PMID:
30789757
45.

Amount of Collagen in the Meat Contained in Japanese Daily Dishes and the Collagen Peptide Content in Human Blood after Ingestion of Cooked Fish Meat.

Asai T, Takahashi A, Ito K, Uetake T, Matsumura Y, Ikeda K, Inagaki N, Nakata M, Imanishi Y, Sato K.

J Agric Food Chem. 2019 Mar 13;67(10):2831-2838. doi: 10.1021/acs.jafc.8b06896. Epub 2019 Mar 5.

PMID:
30784272
46.

Rab33a and Rab33ba mediate the outgrowth of forebrain commissural axons in the zebrafish brain.

Huang L, Urasaki A, Inagaki N.

Sci Rep. 2019 Feb 12;9(1):1799. doi: 10.1038/s41598-018-38468-5.

47.

Food allergy is linked to season of birth, sun exposure, and vitamin D deficiency.

Matsui T, Tanaka K, Yamashita H, Saneyasu KI, Tanaka H, Takasato Y, Sugiura S, Inagaki N, Ito K.

Allergol Int. 2019 Apr;68(2):172-177. doi: 10.1016/j.alit.2018.12.003. Epub 2019 Jan 19. Review.

48.

Generation of mesothelial progenitor-like cells from mouse-induced pluripotent stem cells.

Inagaki NF, Inagaki FF, Kokudo N, Miyajima A.

FEBS Lett. 2019 Feb;593(4):386-394. doi: 10.1002/1873-3468.13325. Epub 2019 Jan 18.

49.

Influence of Nutritional Management and Rehabilitation on Physical Outcome in Japanese Intensive Care Unit Patients: A Multicenter Observational Study.

Yatabe T, Egi M, Sakaguchi M, Ito T, Inagaki N, Kato H, Kaminohara J, Konishi A, Takahashi M, Tatsumi H, Tobe M, Nakashima I, Nakamoto N, Nishimura T, Nitta M, Nishimura M.

Ann Nutr Metab. 2019;74(1):35-43. doi: 10.1159/000495213. Epub 2018 Dec 12.

PMID:
30541003
50.

Novel psychosocial factor involved in diabetes self-care in the Japanese cultural context.

Mano F, Ikeda K, Uchida Y, Liu IH, Joo E, Okura M, Inagaki N.

J Diabetes Investig. 2019 Jul;10(4):1102-1107. doi: 10.1111/jdi.12983. Epub 2019 Jan 3.

Supplemental Content

Loading ...
Support Center